MedPath

Effectiveness of co-oximetry and minimum advice for smoking cessation in kidney transplant recipients

Not Applicable
Completed
Conditions
Smoking in kidney transplant recipients
Mental and Behavioural Disorders
Registration Number
ISRCTN16615772
Lead Sponsor
Complejo Hsopitalario Universitario de A Coruña
Brief Summary

2016 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/27036112 protocol 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33162795/ (added 17/08/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
122
Inclusion Criteria

Smoking kidney transplant recipients, in preparation stage, precontemplation and contemplation stage of change, that give their consent to participate

Exclusion Criteria

Patients with terminal illness or mental disability.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effectiveness will be evaluated at 6 and 12 months by smoking cessation confirmed by nicotine test results.
Secondary Outcome Measures
NameTimeMethod
Abandoned self-declared (by number of cigarettes smoked per day and changes in the dependency stage).
© Copyright 2025. All Rights Reserved by MedPath